相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
Eleni K. Konstantinou et al.
SCIENTIFIC REPORTS (2017)
Optic pathway glioma of childhood
Nailyn Rasool et al.
CURRENT OPINION IN OPHTHALMOLOGY (2017)
Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p
Hong Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
Bing Wei et al.
ONCOTARGETS AND THERAPY (2016)
Malignant optic glioma - the spectrum of disease in a case series
Ghislaine L. Traber et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness
Nicholas Artinian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
Zhongwu Li et al.
MOLECULAR ONCOLOGY (2015)
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
Huabing Zhang et al.
SCIENCE SIGNALING (2015)
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
Huabing Zhang et al.
SCIENCE SIGNALING (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Katarzyna Brodowska et al.
EXPERIMENTAL EYE RESEARCH (2014)
SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
B. Mao et al.
ONCOGENE (2014)
Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
Elizabeth Donohue et al.
PLOS ONE (2014)
Optic nerve glioma: an update
Akshay Gopinathan Nair et al.
INTERNATIONAL OPHTHALMOLOGY (2014)
Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma
Pu-xiang Chen et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2013)
Emerging roles of TEAD transcription factors and its coactivators in cancers
Ajaybabu V. Pobbati et al.
CANCER BIOLOGY & THERAPY (2013)
Differentiating mTOR inhibitors in renal cell carcinoma
Sumanta K. Pal et al.
CANCER TREATMENT REVIEWS (2013)
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
Kamal S. Saini et al.
CANCER TREATMENT REVIEWS (2013)
Treat cancers by targeting survivin: Just a dream or future reality?
Mohane Selvaraj Coumar et al.
CANCER TREATMENT REVIEWS (2013)
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
Florian Ewald et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer
Z. Gu et al.
ONCOGENE (2013)
CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells
Kwang-Beom Lee et al.
CANCER LETTERS (2012)
Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)
Jung-Soon Mo et al.
GENES & DEVELOPMENT (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Primary brain tumours in adults
Damien Ricard et al.
LANCET (2012)
YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29
Karen Tumaneng et al.
NATURE CELL BIOLOGY (2012)
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
A. Fernandez-L et al.
ONCOGENE (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
Dulcie Lai et al.
CANCER RESEARCH (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin
Elizabeth Donohue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
M. Z. Xu et al.
ONCOGENE (2011)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression
Allen C. T. Teng et al.
FASEB JOURNAL (2010)
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
Ian Lian et al.
GENES & DEVELOPMENT (2010)
Oct4 is Expressed in Human Gliomas and Promotes Colony Formation in Glioma Cells
Zhanhui Du et al.
GLIA (2009)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells:: implication for targeted therapy
Tapas K. Sengupta et al.
MOLECULAR CANCER (2007)
The role of autophagy in cancer development and response to therapy
Y Kondo et al.
NATURE REVIEWS CANCER (2005)
Unilateral adult malignant optic nerve glioma
B Wabbels et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Optic pathway gliomas in children with and without neurofibromatosis 1
E Czyzyk et al.
JOURNAL OF CHILD NEUROLOGY (2003)
Aplidin™ induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C δ
LF García-Fernández et al.
ONCOGENE (2002)
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
A Vassilev et al.
GENES & DEVELOPMENT (2001)
分享论文
